GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Polypore International Inc (FRA:QL2) » Definitions » EBITDA per Share

Polypore International (FRA:QL2) EBITDA per Share : €2.37 (TTM As of Jun. 2015)


View and export this data going back to . Start your Free Trial

What is Polypore International EBITDA per Share?

Polypore International's EBITDA per Share for the three months ended in Jun. 2015 was €0.56. Its EBITDA per Share for the trailing twelve months (TTM) ended in Jun. 2015 was €2.37.

During the past 12 months, the average EBITDA per Share Growth Rate of Polypore International was -9.00% per year. During the past 3 years, the average EBITDA per Share Growth Rate was -15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Polypore International's EBITDA per Share or its related term are showing as below:

FRA:QL2' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0   Med: -15.7   Max: 28
Current: -15.7

During the past 12 years, the highest 3-Year average EBITDA per Share Growth Rate of Polypore International was 28.00% per year. The lowest was 0.00% per year. And the median was -15.70% per year.

FRA:QL2's 3-Year EBITDA Growth Rate is not ranked
in the Industrial Products industry.
Industry Median: 10.5 vs FRA:QL2: -15.70

Polypore International's EBITDA for the three months ended in Jun. 2015 was €25.4 Mil.

During the past 12 months, the average EBITDA Growth Rate of Polypore International was -8.70% per year. During the past 3 years, the average EBITDA Growth Rate was -16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 12 years, the highest 3-Year average EBITDA Growth Rate of Polypore International was 32.20% per year. The lowest was 0.00% per year. And the median was -7.70% per year.


Polypore International EBITDA per Share Historical Data

The historical data trend for Polypore International's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polypore International EBITDA per Share Chart

Polypore International Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.03 3.92 2.90 2.28 2.50

Polypore International Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.55 0.67 0.59 0.56

Polypore International EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Polypore International's EBITDA per Share for the fiscal year that ended in Dec. 2014 is calculated as

EBITDA per Share(A: Dec. 2014 )
=EBITDA/Shares Outstanding (Diluted Average)
=113.568/45.382
=2.50

Polypore International's EBITDA per Share for the quarter that ended in Jun. 2015 is calculated as

EBITDA per Share(Q: Jun. 2015 )
=EBITDA/Shares Outstanding (Diluted Average)
=25.43/45.805
=0.56

EBITDA per Share for the trailing twelve months (TTM) ended in Jun. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polypore International  (FRA:QL2) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Polypore International EBITDA per Share Related Terms

Thank you for viewing the detailed overview of Polypore International's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Polypore International (FRA:QL2) Business Description

Traded in Other Exchanges
N/A
Address
Polypore International Inc is a Delaware corporation is a high technology filtration company that develops, manufactures and markets specialized microporous membranes used in separation and filtration processes. The microporous membranes that Company produces are highly engineered polymeric structures that contain millions of pores per square inch, enabling the management of ions, gases and particles that range in size from the cellular to the nano or molecular level. Its operations are mainly managed on a products basis and are comprised of three operating segments that have been aggregated into two reportable segments: energy storage and separations media. The energy storage segment produces and markets membranes that provide the critical function of separating the cathode and anode in a variety of battery markets, including lithium, industrial and transportation applications. The separations media segment produces and markets membranes used as the high technology filtration element in various medical and industrial applications. Electronics applications: The Company develops, manufactures and markets a line of patented polypropylene and polyethylene monolayer and multilayer membrane separators for lithium batteries that are used in numerous applications such as personal electronic devices, cordless power tools and HEVs and other electric vehicles. Transportation and industrial applications: Polypore develops, manufactures and markets a complete line of high-performance polymer-based membrane separators for lead-acid batteries. Approximately 80% of its lead-acid battery separators are used in batteries for automobiles and other motor vehicles. The Company develops, manufactures and markets a complete line of patented polyethersulfone membranes for the hemodialysis market. Hemodialysis is the artificial process that performs the function of a healthy kidney for patients with permanent kidney failure, a condition known as End Stage Renal Disease. Polypore develops, manufactures and markets polypropylene and polymethylpentene membranes for the blood oxygenation market. As a component of heart-lung machines, blood oxygenators temporarily replace the functions of the lungs during on-pump open-heart surgery. The Company develops, manufactures and markets polypropylene and polyethersulfone membranes for the plasmapheresis market. In plasmapheresis, plasma is separated from the blood and either retained for the production of therapeutic proteins or filtered and returned to the blood as a treatment for various autoimmune disorders. Polypore produces a range of membranes and membrane-based elements for micro- and ultrafiltration and gasification/degasification of liquids, covering a range of applications in the filtration market. The Company sells its products and services to customers in both the domestic and international marketplace. Polypore sells mainly to manufacturers and converters that incorporate its products into their finishe

Polypore International (FRA:QL2) Headlines

No Headlines